Last reviewed · How we verify
Chitosan-Hyaluronate Gel Mixture
Chitosan-hyaluronate gel provides a biocompatible matrix that promotes wound healing and tissue regeneration through hydration, cell adhesion support, and anti-inflammatory properties.
Chitosan-hyaluronate gel provides a biocompatible matrix that promotes wound healing and tissue regeneration through hydration, cell adhesion support, and anti-inflammatory properties. Used for Wound healing and tissue regeneration, Burn wounds, Surgical wounds.
At a glance
| Generic name | Chitosan-Hyaluronate Gel Mixture |
|---|---|
| Sponsor | Ain Shams University |
| Drug class | Biomaterial/Wound healing agent |
| Modality | Small molecule |
| Therapeutic area | Dermatology/Wound Care |
| Phase | FDA-approved |
Mechanism of action
Chitosan is a natural polysaccharide with antimicrobial and hemostatic properties, while hyaluronate is a key extracellular matrix component that promotes cell migration and hydration. Together, they form a gel scaffold that maintains a moist wound environment, facilitates cell proliferation, and reduces inflammation, accelerating tissue repair and regeneration.
Approved indications
- Wound healing and tissue regeneration
- Burn wounds
- Surgical wounds
Common side effects
- Local irritation or erythema
- Allergic reaction
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Chitosan-Hyaluronate Gel Mixture CI brief — competitive landscape report
- Chitosan-Hyaluronate Gel Mixture updates RSS · CI watch RSS
- Ain Shams University portfolio CI